These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 26768891)
1. Heterogeneity of intrahepatic fat distribution determined by (18)F-FDG PET and CT. Keramida G; Hunter J; Dizdarevic S; Peters AM Ann Nucl Med; 2016 Apr; 30(3):200-6. PubMed ID: 26768891 [TBL] [Abstract][Full Text] [Related]
2. Accumulation of (18)F-FDG in the liver in hepatic steatosis. Keramida G; Potts J; Bush J; Verma S; Dizdarevic S; Peters AM AJR Am J Roentgenol; 2014 Sep; 203(3):643-8. PubMed ID: 25148170 [TBL] [Abstract][Full Text] [Related]
3. Hepatic steatosis is associated with increased hepatic FDG uptake. Keramida G; Potts J; Bush J; Dizdarevic S; Peters AM Eur J Radiol; 2014 May; 83(5):751-5. PubMed ID: 24581596 [TBL] [Abstract][Full Text] [Related]
4. Relationships of body habitus and SUV indices with signal-to-noise ratio of hepatic (18)F-FDG PET. Keramida G; Dunford A; Siddique M; Cook GJ; Peters AM Eur J Radiol; 2016 May; 85(5):1012-5. PubMed ID: 27130064 [TBL] [Abstract][Full Text] [Related]
5. Dynamics of fluorine-18-fluorodeoxyglucose uptake in the liver and its correlation with hepatic fat content and BMI. Seraj SM; Al-Zaghal A; Zadeh MZ; Jahangiri P; Pournazari K; Raynor WY; Werner TJ; Høilund-Carlsen PF; Alavi A; Hunt SJ Nucl Med Commun; 2019 May; 40(5):545-551. PubMed ID: 30807535 [TBL] [Abstract][Full Text] [Related]
6. Standardized uptake values for [¹⁸F] FDG in normal organ tissues: comparison of whole-body PET/CT and PET/MRI. Heusch P; Buchbender C; Beiderwellen K; Nensa F; Hartung-Knemeyer V; Lauenstein TC; Bockisch A; Forsting M; Antoch G; Heusner TA Eur J Radiol; 2013 May; 82(5):870-6. PubMed ID: 23394765 [TBL] [Abstract][Full Text] [Related]
7. New exponential functions based on CT density to estimate the percentage of liver that is fat. Keramida G; Peters AM Br J Radiol; 2017 Jul; 90(1075):20170186. PubMed ID: 28541123 [TBL] [Abstract][Full Text] [Related]
8. Uptake in supraclavicular area fat ("USA-Fat"): description on 18F-FDG PET/CT. Cohade C; Osman M; Pannu HK; Wahl RL J Nucl Med; 2003 Feb; 44(2):170-6. PubMed ID: 12571205 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of hepatic metabolic activity in non-alcoholic fatty livers on 18FDG PET/CT. Dostbil Z; Varoğlu E; Serdengeçti M; Kaya B; Onder H; Sari O Rev Esp Med Nucl Imagen Mol; 2013; 32(3):156-61. PubMed ID: 23177332 [TBL] [Abstract][Full Text] [Related]
10. Effect of hepatic steatosis on liver FDG uptake measured in mean standard uptake values. Abele JT; Fung CI Radiology; 2010 Mar; 254(3):917-24. PubMed ID: 20177102 [TBL] [Abstract][Full Text] [Related]
11. Correlation between standardized uptake value and apparent diffusion coefficient of neoplastic lesions evaluated with whole-body simultaneous hybrid PET/MRI. Rakheja R; Chandarana H; DeMello L; Jackson K; Geppert C; Faul D; Glielmi C; Friedman KP AJR Am J Roentgenol; 2013 Nov; 201(5):1115-9. PubMed ID: 24147485 [TBL] [Abstract][Full Text] [Related]
12. Nonionic intravenous contrast agent does not cause clinically significant artifacts to 18F-FDG PET/CT in patients with lung cancer. An YS; Sheen SS; Oh YJ; Hwang SC; Yoon JK Ann Nucl Med; 2007 Dec; 21(10):585-92. PubMed ID: 18092135 [TBL] [Abstract][Full Text] [Related]
13. Hepatic steatosis: correlations of body mass index, CT fat measurements, and liver density with biopsy results. Gaba RC; Knuttinen MG; Brodsky TR; Palestrant S; Omene BO; Owens CA; Bui JT Diagn Interv Radiol; 2012; 18(3):282-7. PubMed ID: 22258794 [TBL] [Abstract][Full Text] [Related]
14. (18)F-FDG and (18)F-FLT PET/CT imaging in the characterization of mediastinal lymph nodes. Rayamajhi SJ; Mittal BR; Maturu VN; Agarwal R; Bal A; Dey P; Shukla J; Gupta D Ann Nucl Med; 2016 Apr; 30(3):207-16. PubMed ID: 26661845 [TBL] [Abstract][Full Text] [Related]
15. Differentiating the grades of thymic epithelial tumor malignancy using textural features of intratumoral heterogeneity via (18)F-FDG PET/CT. Lee HS; Oh JS; Park YS; Jang SJ; Choi IS; Ryu JS Ann Nucl Med; 2016 May; 30(4):309-19. PubMed ID: 26868139 [TBL] [Abstract][Full Text] [Related]
16. Altered hepatic metabolic activity in patients with hepatic steatosis on FDG PET/CT. Abikhzer G; Alabed YZ; Azoulay L; Assayag J; Rush C AJR Am J Roentgenol; 2011 Jan; 196(1):176-80. PubMed ID: 21178064 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of neuroendocrine liver metastases: a comparison of dynamic contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography. Armbruster M; Sourbron S; Haug A; Zech CJ; Ingrisch M; Auernhammer CJ; Nikolaou K; Paprottka PM; Rist C; Reiser MF; Sommer WH Invest Radiol; 2014 Jan; 49(1):7-14. PubMed ID: 24002080 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of CT-based lean-body SUV. Hamill JJ; Sunderland JJ; LeBlanc AK; Kojima CJ; Wall J; Martin EB Med Phys; 2013 Sep; 40(9):092504. PubMed ID: 24007180 [TBL] [Abstract][Full Text] [Related]
19. Assessing the Effect of Various Blood Glucose Levels on Sarikaya I; Sarikaya A; Sharma P J Nucl Med Technol; 2019 Dec; 47(4):313-318. PubMed ID: 31182660 [TBL] [Abstract][Full Text] [Related]
20. The value of skeletal standardized uptake values obtained by quantitative single-photon emission computed tomography-computed tomography in differential diagnosis of bone metastases. Zhang Y; Li B; Yu H; Song J; Zhou Y; Shi H Nucl Med Commun; 2021 Jan; 42(1):63-67. PubMed ID: 33044406 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]